申请人:Abbott Laboratories
公开号:US05399699A1
公开(公告)日:1995-03-21
Compounds of the structure ##STR1## where A.sub.1 is alkylene or cycloalkylene; A.sub.2 is a valence bond, alkylene, or cycloalkylene; R.sub.1 is selected from hydrogen, alkylthio, optionally substituted phenylthio, optionally substituted phenylalkylthio, optionally substituted 2-, 3- and 4-pyridylthio, optionally substituted 2- and 3-thienylthio, and optionally substituted 2-thiazolylthio; R.sup.2 is selected from optionally substituted phenylalkyl and optionally substituted heteroarylakyl; R.sup.3 is selected from alkyl, alkoxy, optionally substituted phenyl, optionally substituted phenoxy, optionally substituted phenylalkyl, optionally substituted phenylalkoxy, optionally substituted naphthyl,optionally substituted naphthyloxy, optionally substituted naphthylalkyl, optionally substituted naphthylalkoxy, optionally substituted heteroaryl, optionally substituted heteroaryloxy, optionally substituted heteroarylalkyl, and optionally substituted heteroarylalkoxy; R.sup.4 is selected from hydrogen and optionally substituted alkyl; and Z is selected from --COOB, --C(OB)R.sup.6 R.sup.6, --COOalkyl, --COOalkylaryl, --CONR.sup.5 R.sup.6, and --COR.sup.6 are potent inhibitors of lipoxygenase enzymes and thus inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment of amelioration of allergic and inflammatory disease states.
结构为##
STR1##的化合物,其中A.sub.1为烷基或
环烷基;A.sub.2为价键,烷基或
环烷基;R.sub.1从
氢、烷基
硫、可选择取代的
苯硫、可选择取代的
苯烷
硫、可选择取代的2-、3-和4-
吡啶硫、可选择取代的2-和3-
噻吩硫、以及可选择取代的2-
噻唑硫中选择;R.sup.2从可选择取代的
苯烷基和可选择取代的杂
环烷基中选择;R.sup.3从烷基、烷
氧基、可选择取代的
苯基、可选择取代的
苯氧基、可选择取代的
苯烷基、可选择取代的
苯烷
氧基、可选择取代的
萘基、可选择取代的
萘氧基、可选择取代的
萘烷基、可选择取代的
萘烷氧基、可选择取代的杂环基、可选择取代的杂环
氧基、可选择取代的杂
环烷基、以及可选择取代的杂
环烷氧基中选择;R.sup.4从
氢和可选择取代的烷基中选择;Z从--COOB、--C(OB)R.sup.6 R.sup.6、--COO烷基、--COO烷基芳基、--CONR.sup.5 R.sup.6和--COR.sup.6中选择,是脂
氧酶酶的有效
抑制剂,从而抑制
白三烯的
生物合成。这些化合物对于治疗和缓解过敏和炎症性疾病状态非常有用。